Cite
HARVARD Citation
Zhu, H. et al. (n.d.). All‐trans retinoic acid and arsenic combination therapy benefits low‐to‐intermediate‐risk patients with newly diagnosed acute promyelocytic leukaemia: a long‐term follow‐up based on multivariate analysis. British journal of haematology. pp. 277-280. [Online].